Journal of Pharmaceutical Innovation, Journal Year: 2024, Volume and Issue: 19(6)
Published: Dec. 1, 2024
Language: Английский
Journal of Pharmaceutical Innovation, Journal Year: 2024, Volume and Issue: 19(6)
Published: Dec. 1, 2024
Language: Английский
Medicine in Drug Discovery, Journal Year: 2025, Volume and Issue: unknown, P. 100204 - 100204
Published: Feb. 1, 2025
Language: Английский
Citations
2Journal of Porous Materials, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 16, 2025
Language: Английский
Citations
1Gels, Journal Year: 2024, Volume and Issue: 10(6), P. 356 - 356
Published: May 22, 2024
Mesoporous silica nanoparticles (MSNs) are inorganic nanocarriers presenting versatile properties and the possibility to deliver drug molecules via different routes of application. Their modification with lipids could diminish burst release profile for water-soluble molecules. In case oleic acid (OA) as a lipid component, an improvement in skin penetration can be expected. Therefore, present study, aminopropyl-functionalized MSNs were modified through carbodiimide chemistry subsequently incorporated into semisolid hydrogel dermal delivery. Doxorubicin served model drug. The FT-IR XRD analysis well ninhydrin reaction showed successful preparation proposed nanocarrier uniform particle size (352–449 nm) negative zeta potential. Transmission electron microscopy was applied evaluate any possible changes morphology. High encapsulation efficiency (97.6 ± 1.8%) achieved together sustained over 48 h. composite hydrogels containing OA-modified characterized by excellent physiochemical (pH 6.9; occlusion factor 53.9; spreadability 2.87 viscosity 1486 Pa·s) vitro permeation study 2.35 fold compared free cell studies that loading significantly improved doxorubicin’s cytotoxic effects toward epidermoid carcinoma cells (A431). All results suggest prepared has potential delivery doxorubicin treatment cancer.
Language: Английский
Citations
3International Journal of Pharmaceutics, Journal Year: 2025, Volume and Issue: unknown, P. 125385 - 125385
Published: Feb. 1, 2025
Language: Английский
Citations
0Journal of Drug Delivery Science and Technology, Journal Year: 2025, Volume and Issue: unknown, P. 106924 - 106924
Published: April 1, 2025
Language: Английский
Citations
0Heliyon, Journal Year: 2024, Volume and Issue: 10(8), P. e29460 - e29460
Published: April 1, 2024
This research aimed to enhance dermal delivery and optimize depigmentation therapy by designing mesoporous silica nanoparticles (MSNs) encapsulating azelaic acid (AZA) within a gel matrix. The MSNs were prepared using the sol-gel method. After subsequent processes, including extraction drug loading, then elucidated through PDI, size, zeta-potential, entrapment efficiency, nitrogen adsorption assay, FE-SEM, thermogravimetric analysis, differential scanning calorimetry, Fourier transform infrared spectroscopy, X-ray diffraction, tyrosinase inhibition employed assess formulation.
Language: Английский
Citations
2Journal of Pharmaceutical Innovation, Journal Year: 2024, Volume and Issue: 19(6)
Published: Dec. 1, 2024
Language: Английский
Citations
1